Skip to main content

December 2013

 

 

academics

 

Clinical research courses

HNBGU invites Assistant Professors, Associate Professors, Professors for Pharmaceutical Sciences - 9 posts

Applications in the prescribed form are invited from the eligible candidates for the following posts shown against the subjects to be filled up on regular basis. Those applicants who have applied against our Advt. No. Admn/2011/3541 Dated 18.2.2011 and Advt. No. HNBGU/ADMN/Recruitment-01/2011 and 02/2011 for the post of Professor, Associate Professor and Assistant Professor under the SCHOOL of ARTS, COMMUNICATION AND LANGUAGES, HUMANITIES AND SOCIAL SCIENCES, COMMERCE, EARTH SCIENCES, AND IN THE DEPARTMENT OF APPLIED SCIENCES OF SCHOOL OF ENGINEERING, PHARMACEUTICAL CHEMISTRY, PROFESSOR IN MANAGEMENT AND ASSISTANT PROFESSOR IN EDUCATION are also required to apply again in the prescribed application form and make payment of Rs. 50/- as re-registration fee , however they are exempted from application fee of Rs. 500/ for UR/OBC category or Rs. 300/ for SC/ST/PWD category. Last date of receiving of duly completed application form is 17.01.2014.

Post: Assistant Professors, Associate Professors, Professors

Opening for DEPUTY VICE PRESIDENT (MARKETING) at HLL Lifecare | Annual CTC Rs.13.1 lakhs

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Walk in for M.Pharm or M.Sc in DST sponsored project as Junior Research Fellow in Central University of Punjab

The Central University of Punjab, Bathinda (Punjab) has been established through the Central Universities Act 2009 which received the assent of the President of India on 20th March 2009. Its territorial jurisdiction extends to the whole State of Punjab. This newly set up Central University of Punjab (CUP) at Bathinda is poised to write new alphabet on the academic horizon of India.

BITSAT for admission in M.Pharm at Birla Institute of Technology & Science

The Birla Institute of Technology and Science (BITS) Pilani is an all India Institution declared as Deemed to be University under Section 3 of the UGC Act. Admissions to all the Integrated First Degree programmes of BITS, Pilani, at Pilani campus, Goa campus, and Hyderabad Campus for the academic year 2014 - 15 will be made on the basis of a Computer based Online Test conducted by BITS, Pilani. This test will be referred to as ‘BITS Admission Test – 2014; in short as BITSAT - 2014 hereafter in this document.

BITSAT  is a Computer based online test for Admission to Integrated First Degree Programmes of BITS Pilani Campuses in Pilani, Goa and Hyderabad.

LIVER CIRRHOSIS: A REVIEW

ABOUT AUTHORS:
Kambham Venkateswarlu1*, N.Devann2, R.Venu Priya3, P.Bharath Rathna Kumar4
1M.Pharm Scholar, Department Of PharmaCEUTICS,
2Director Of JNTUA-Otri,
3Faculty Of Pharmacy, Department Of Pharmaceutics,
4Faculty Of Pharmacy, Department Of Pharmaceutical Chemistry,
JNTUA-Oil Technological Research Institute,
Beside Collector Office, Anantapur, Anantapur District, Andhra Pradesh, India.
Pin Code: 515001

ABSTRACT:
Cirrhosis is defined as the histological development of regenerative nodules of liver parenchyma surrounded by fibrous septa in response to chronic liver injury. Chronic liver diseases represent a significant health problem across the globe with liver cirrhosis,an end stage consequence of fibrosis, being the major medical emergency with significant morbidity and mortality.
The exact prevalence of this life threatening disease worldwide is unknown as clinical spectrum of cirrhosis ranges from indolent, asymptomatic to complete hepatic decompensation. The progression of fibrosis to cirrhosis is lower in women than men due tothe protection offered by oestrogens. The ultimate curative option for liver cirrhosis currently is liver transplantation, which poses significant risk to the patient.